🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
306,20 USD
Máx. histórico
322,75
7 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-5,13%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,41%
Cierre anterior
299,00
Rango de hoy
297,84 – 308,26
Volumen hoy
130.173
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 122,97 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 351,33 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 10 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 11/10/2017 | 89,74 | 90,04 | 88,41 | 89,33 | -0,01% | 1,82% | 327.172 |
| 10/10/2017 | 88,84 | 89,37 | 87,90 | 89,34 | +0,58% | 1,65% | 349.775 |
| 09/10/2017 | 88,43 | 89,36 | 88,02 | 88,82 | +0,54% | 1,52% | 255.999 |
| 06/10/2017 | 87,27 | 88,55 | 87,20 | 88,34 | +1,05% | 1,54% | 299.280 |
| 05/10/2017 | 87,27 | 87,74 | 86,57 | 87,42 | +1,09% | 1,34% | 521.616 |
| 04/10/2017 | 86,00 | 86,71 | 85,41 | 86,48 | +1,06% | 1,52% | 238.687 |
| 03/10/2017 | 85,12 | 85,68 | 84,32 | 85,57 | +0,85% | 1,60% | 306.814 |
| 02/10/2017 | 85,40 | 85,45 | 83,94 | 84,85 | -0,10% | 1,78% | 322.363 |
| 29/09/2017 | 84,16 | 85,46 | 83,89 | 84,93 | +1,08% | 1,87% | 396.582 |
| 28/09/2017 | 83,91 | 84,17 | 82,80 | 84,03 | +0,28% | 1,64% | 450.764 |
| 27/09/2017 | 84,36 | 84,92 | 83,76 | 83,79 | -0,39% | 1,38% | 377.346 |
| 26/09/2017 | 85,01 | 85,33 | 83,79 | 84,12 | -0,74% | 1,81% | 252.953 |
| 25/09/2017 | 84,79 | 85,86 | 84,52 | 84,75 | +0,23% | 1,58% | 363.560 |
| 22/09/2017 | 84,74 | 84,87 | 83,59 | 84,56 | -0,19% | 1,51% | 236.923 |
| 21/09/2017 | 85,08 | 85,35 | 84,45 | 84,72 | -0,42% | 1,06% | 829.392 |
| 20/09/2017 | 85,02 | 85,17 | 84,04 | 85,08 | +0,15% | 1,33% | 232.114 |
| 19/09/2017 | 84,74 | 84,98 | 84,21 | 84,95 | +0,76% | 0,91% | 614.270 |
| 18/09/2017 | 83,89 | 84,96 | 83,89 | 84,31 | +0,33% | 1,28% | 425.276 |
| 15/09/2017 | 84,62 | 85,05 | 83,52 | 84,03 | -0,44% | 1,80% | 981.036 |
| 14/09/2017 | 85,84 | 85,89 | 84,11 | 84,40 | -1,91% | 2,07% | 667.489 |
| 13/09/2017 | 86,03 | 86,39 | 85,67 | 86,05 | +0,01% | 0,84% | 535.562 |
| 12/09/2017 | 84,72 | 86,07 | 83,67 | 86,04 | +1,12% | 2,83% | 694.901 |
| 11/09/2017 | 85,28 | 86,07 | 84,49 | 85,08 | -0,21% | 1,85% | 323.646 |
| 08/09/2017 | 84,27 | 85,50 | 83,52 | 85,27 | +0,89% | 2,35% | 378.148 |
| 07/09/2017 | 83,62 | 84,69 | 83,08 | 84,52 | +1,45% | 1,92% | 482.663 |
| 06/09/2017 | 81,86 | 83,58 | 81,19 | 83,31 | +2,05% | 2,92% | 637.193 |
| 05/09/2017 | 81,10 | 82,65 | 80,09 | 81,64 | +1,50% | 3,16% | 456.855 |
| 01/09/2017 | 80,82 | 80,96 | 79,60 | 80,43 | +0,05% | 1,68% | 217.527 |
| 31/08/2017 | 79,47 | 80,85 | 78,80 | 80,39 | +1,53% | 2,59% | 426.719 |
| 30/08/2017 | 79,16 | 79,29 | 78,33 | 79,18 | +0,03% | 1,21% | 253.434 |